SCHEMBL24433096

SCHEMBL24433096

COc1ccc(C(=O)NC(C)C)c2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 1/20 0.71
▸ HPGDS O60760 1/20 0.56
▸ CDC25B P30305 2/20 0.55
▸ KMT2A Q03164 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ HPGD P15428 2/20 0.52
▸ GAA P10253 2/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ CYP2C9 P11712 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ STAT6 P42226 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ LMNA P02545 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MEN1 O00255 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13164717 0.88 PLK1 (0.51) PLK1KMT2AMAPTHPGDGAA
SCHEMBL11962157 0.83 PLK1 (1.00) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL2005312 0.83 PLK1 (1.00) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL31315042 0.83 PLK1 (0.76) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL5891933 0.82 PLK1 (0.73) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL13184544 0.81 PLK1 (0.63) PLK1KMT2AMAPTHPGDGAA
SCHEMBL18893131 0.80 L3MBTL1 (0.74) MAPTHPGDGAAALDH1A1HSD17B10
SCHEMBL24101354 0.80 PLK1 (0.70) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL4469856 0.78 CDC25B (0.78) PLK1HPGDSCDC25BKMT2AMAPT
SCHEMBL7842295 0.78 PLK1 (0.67) PLK1HPGDSCDC25BKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 HDAC10, HDAC1, HDAC11 PLK1 1289/4885HPGDS 2270/4885CDC25B 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback